Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

Autor: José I. Fernández-Velasco, Enric Monreal, Jens Kuhle, Virginia Meca-Lallana, José Meca-Lallana, Guillermo Izquierdo, Celia Oreja-Guevara, Francisco Gascón-Giménez, Susana Sainz de la Maza, Paulette E. Walo-Delgado, Paloma Lapuente-Suanzes, Aleksandra Maceski, Eulalia Rodríguez-Martín, Ernesto Roldán, Noelia Villarrubia, Albert Saiz, Yolanda Blanco, Carolina Diaz-Pérez, Gabriel Valero-López, Judit Diaz-Diaz, Yolanda Aladro, Luis Brieva, Cristina Íñiguez, Inés González-Suárez, Luis A Rodríguez de Antonio, José M. García-Domínguez, Julia Sabin, Sara Llufriu, Jaime Masjuan, Lucienne Costa-Frossard, Luisa M. Villar

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

ObjectiveTo ascertain the role of inflammation in the response to ocrelizumab in primary-progressive multiple sclerosis (PPMS).MethodsMulticenter prospective study including 69 patients with PPMS who initiated ocrelizumab treatment, classified accord

Externí odkaz: https://doaj.org/article/c8e040513ca84c5f9b5252521e717dd6

Neurological presentations of COVID-19: Findings from the Spanish Society of Neurology neuroCOVID-19 registry

Autor: David García-Azorín, María José Abenza Abildúa, María Elena Erro Aguirre, Santiago Fernández Fernández, Juan Carlos García Moncó, Cristina Guijarro-Castro, Montserrat González Platas, Fernando Romero Delgado, José Miguel Láinez Andrés, David Ezpeleta, Alejandra Collía Fernández, Alejandro Horga, Ana Barragán Prieto, Ana del Villar Igea, Ana Urbanos Núñez, Ángel Aledo Serrano, Araceli García, Beatriz Martínez Menéndez, Bernat Bertran Recasens, Blanca Serrano Serrano, Blanca Talavera de la Esperanza, Carlos Pablo de Fuenmayor Fernández de la Hoz, Carlos Tejero Juste, Carmen Valderrama Martín, Cristina Fernández García, Marta Ochoa, Cristina Íñiguez, Daniel Macías García, David A. Pérez Martínez, Débora Mª. Cerdán Santacruz, Misericòrdia Floriach Robert, Elisabet Franquet Gomez, Elsa Puiggròs, Eric Freire Álvarez, Esteban Peña Llamas, Estibaliz Villareal, Eva Fernández Díaz, Fernando Morejón Burguillos, Garazi Agirre Beitia, Gerardo Gutiérrez-Gutiérrez, Guilherme Carvalho Monteiro, Guillermo Cervera Ygual, Guillermo Hernández, Guillermo Rubio, Hortenia Alonso, Iago Payo Froiz, Iago Rego García, Inmaculada Redondo Peñas, Javier R. Pérez Sánchez, Javier Tejada García, Javier Villacieros Álvarez, Jéssica Fernández Domínguez, Jesús Porta Etessam, Jon Equiza, Jorge Millán Pascual, José Antonio Oliván Usieto, José Antonio Reyes, José Balseiro Gómez, José Carlos Roche Bueno, Jose Luis Camacho Velasquez, José María Barrios López, Leire Ainz Raquel Lamas, Lidia Binela Lara Lezama, Lorena Caballero, Lucía Galan Davila, Nuria González, Luis Alberto Rodríguez de Antonio, Mª. Araceli García Torres, Maite Martinez Zabaleta, Manuel Medina Rodríguez, María Dolores Moragues, María Fuensanta Valero García, María Hernández, María Rabasa, María Rico Santos, María Usero, Martín Zurdo, Miguel Más, Miren Maneiro, null Muriana, Noelia González Nafría, Oriol Barrachina Esteve, Pablo del Saz Saucedo, null Rocío, Rosa M. Vilar Ventura, Saida Atienza, Sandra Rodríguez Navas, Sergio Borja, Silvia Gil Navarro, Solange Kapetanovic García, Susana García, Teresa Mateos Salas, Toni Palasí, Victoriano Romero Cantero

Publikováno v: Journal of the Neurological Sciences

Objective We report the findings from the Spanish Society of Neurology's NeuroCOVID-19 Registry. Methods We performed a multicentre study of patients with neurological manifestations of COVID-19. Participating physicians reported demographic, clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67f75c0e00e8f52ccd1cf62d3931de39
https://doi.org/10.1016/j.jns.2020.117283

Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation

Autor: Aida Orviz, Cristina Valencia, Inés González-Suárez, Manuela Jorquera Moya, Luis A. Rodríguez de Antonio, Jordi A. Matías-Guiu, Sara Moreno-García, María D. Valle-Arcos, Celia Oreja-Guevara

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Brain and Behavior

Introduction Natalizumab (NTZ) is an effective drug for the treatment of relapsing-remitting multiple sclerosis. In some patients discontinuation is mandatory due to the risk of progressive multifocal leukoencephalopathy. However, severe clinical and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aef5086b68d39376704b652d14cfe05
https://hdl.handle.net/20.500.12530/39768

'Píldora del día después' e ictus: un nuevo caso

Autor: Luis Alberto Rodríguez de Antonio, Blanca Fuentes, Exuperio Díez-Tejedor, María José Aguilar-Amat

Publikováno v: Medicina Clínica. 136:647-648

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7132d0f558230cf7297e24a22df8bd73
https://doi.org/10.1016/j.medcli.2010.05.020